Surinder Batra, PhD
Associate Director, Nanovaccine Institute
Professor and Chairman, Department of Biochemistry & Molecular Biology, College of Medicine
Associate Director for Education and Training, Fred & Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer, University of Nebraska Medical Center
University of Nebraska Medical Center
PhD, Kurukshetra University (NDRI), INDIA, 1983
Stragier, L’institut national de la recherché agronomique (INRA)
Tours, France, 1982-83
Post-doctoral Fellow, North Carolina State University, Raleigh, NC, USA, 1983-1986
Research Associate Post-doctoral Fellow, Duke University Medical Center, Durham, USA, 1988-1991
Research interest: Tumor-associated genes; cancer diagnostics, cancer vaccines; monoclonal antibodies, genetic engineering of antibodies.
The overall goals of our laboratory are to study the molecular mechanisms of neoplastic transformation, differentiation, and altered growth in human pancreatic, colorectal, prostate, and brain tumors. Normal cell proliferation is under the intrinsic control of growth-promoting proto-oncogenes and growth-constraining anti-oncogenes.
Specifically, we are defining the multifaceted roles of tumor-associated antigens (MUC4, MUC5AC, MUC16 (CA125), MUC17, and PD2/hPaf1) in the pathogenesis and targeting of multiple cancers.